ALTERED ENFOTHELIAL FUNCTION AS A CARDIOVASCULAR RISK INDEX IN PATIENTS WITH METABOLIC SYNDROME

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2005-001024-36-IT

Enrollment

Registered

2007-03-05

Start date

2005-04-11

Completion date

Unknown

Last updated

2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

METABOLIC SYNDROME MedDRA version: 9.1 Level: LLT Classification code 10048554 Term: Endothelial dysfunction

Interventions

Trade Name: BIOARGININA*OS 20FL 1,66G/20ML Product Name: LEVOARGININA Pharmaceutical Form: Oral solution CAS Number: 1119-34-2 Concentration unit: g gram(s) Concentration type: equal Concentration n

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026